Does Qiliqiangxin therapy attenuate cardiac remodeling in a rat model of myocardial infarction?
Qiliqiangxin therapy attenuates cardiac remodeling, preserves cardiac function, and reduces inflammation and fibrosis in a rat model of myocardial infarction.
QL therapy exerted protective effects against cardiac remodeling potentially by inhibiting TGF-β1/Smad3 and NF-κB signaling pathways, thereby preserving cardiac function, as well as reducing myocardial inflammation and fibrosis.
Han et al. (2018) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: